Inhibition of Ebola virus glycoprotein-mediated cytotoxicity by targeting its transmembrane domain and cholesterol
Open Access
- 9 July 2015
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 6 (1) , 7688
Abstract
The high pathogenicity of the Ebola virus reflects multiple concurrent processes on infection. Among other important determinants, Ebola fusogenic glycoprotein (GP) has been associated with the detachment of infected cells and eventually leads to vascular leakage and haemorrhagic fever. Here we report that the membrane-anchored GP is sufficient to induce the detachment of adherent cells. The results show that the detachment induced through either full-length GP1,2 or the subunit GP2 depends on cholesterol and the structure of the transmembrane domain. These data reveal a novel molecular mechanism in which GP regulates Ebola virus assembly and suggest that cholesterol-reducing agents could be useful as therapeutics to counteract GP-mediated cell detachment.Keywords
This publication has 68 references indexed in Scilit:
- Stiffened lipid platforms at molecular force fociProceedings of the National Academy of Sciences, 2013
- Update on activities at the Universal Protein Resource (UniProt) in 2013Nucleic Acids Research, 2012
- The Ebola Virus Glycoprotein and HIV-1 Vpu Employ Different Strategies to Counteract the Antiviral Factor TetherinThe Journal of Infectious Diseases, 2011
- Ebola virus entry requires the cholesterol transporter Niemann–Pick C1Nature, 2011
- Ebola haemorrhagic feverThe Lancet, 2011
- Steric Shielding of Surface Epitopes and Impaired Immune Recognition Induced by the Ebola Virus GlycoproteinPLOS Pathogens, 2010
- CD-HIT Suite: a web server for clustering and comparing biological sequencesBioinformatics, 2010
- Ebolavirus Glycoprotein GP Masks both Its Own Epitopes and the Presence of Cellular Surface ProteinsJournal of Virology, 2009
- Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoproteinVirology, 2009
- Differential Cholesterol Binding by Class II Fusion Proteins Determines Membrane Fusion PropertiesJournal of Virology, 2008